SARAH PUCCINELLI: Open Payments
NPI 1760519912 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 49 payments from 17 companies in 2025. Trend: 2023 $846 · 2024 $871 · 2025 $1,168
Food & beverage: $1,168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $271 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| REVANCE THERAPEUTICS, INC. | 1 | $130 |
| Amgen Inc. | 5 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $80 |
| UCB, Inc. | 2 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Janssen Biotech, Inc. | 3 | $60 |
| Incyte Corporation | 2 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $44 |
Products named: SKYRIZI, DAXXIFY, OTEZLA, RINVOQ, COSENTYX, SPEVIGO, Bimzelx, DUPIXENT.
Industry payments across FL — which companies pay providers there.
